Therapeutics

Cidara Therapeutics Announces Commencement of Concurrent Public Offerings of Common Stock and Preferred Stock

8 days ago   |   By San Diego Biotechnology

SAN DIEGO, Oct. 07, 2021 - Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that it has commenced concurrent but separate underwritten public offerings of its common stock and its...
Read more ...

 

Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS G12C-mutated Lung Cancer

8 days ago   |   By San Diego Biotechnology

SAN DIEGO: SAN DIEGO, Oct. 7, 2021 /PRNewswire/ - Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, today announced a non-exclusive clinical collaboration agreement with Sanofi to evaluate the combination of adagrasib, the Company's investigational KRASG12C inhibitor, with Sanofi's investigational SHP2 inhibitor SAR442720, also known as RMC-4630. The...
Read more ...

 

Plexium to Present at the Solebury Trout/BMO Fall Private Company Showcase 2021

8 days ago   |   By San Diego Biotechnology

SAN DIEGO: SAN DIEGO, Oct. 7, 2021 /PRNewswire/ - Plexium, Inc., , a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, today announced that company management will present and host one-on-one meetings at the Solebury Trout/BMO Fall Private Company Showcase 2021. The...
Read more ...

 


Search by Tags

   Therapeutics      BioTechnology      News      Nasdaq      CDTXUS1717571079      Cancer      Clinical      Drug      Protein      Drugs      Biotech      BioTech  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Cellular environments shape molecular architecture

An important cellular structure called the nuclear pore complex has larger dimensions than previously thought. A research team made this discovery using cryo-focused ion beam... Read more ...

Sr Scientist - Protein Sciences - Novartis / NIBR / GNF / San Diego...

High degree of self-motivation and attention to detail. Support the collection of analytical data. Present scientific and technical work.From Novartis - Sat, 16 Oct 2021... Read more ...

Benchmarking sequencing methods and tools that facilitate the study of...

Alternative cleavage and polyadenylation , an RNA processing event, occurs in over 70% of human protein-coding genes. APA results in mRNA transcripts with distinct 3′ ends... Read more ...

A global screening identifies chromatin-enriched RNA-binding proteins and...

Cellular RNA-binding proteins have multiple roles in post-transcriptional control, and some are shown to bind DNA. However, the global localization and the general... Read more ...

KrasG12D induces changes in chromatin territories that differentially impact...

Pancreatic ductal adenocarcinoma initiation is most frequently caused by Kras mutations. Read more ...

San Diego biotech veterans launch novel therapeutics firm targeting cancer...

Tentarix comes out of stealth mode, raises $50 million in venture funding led by Versant Ventures, Samsara BioCapital Read more ...

Genetic and process engineering strategies for enhanced recombinant...

The production of N-linked glycoproteins in genetically amenable bacterial hosts offers great potential for reduced cost, faster/simpler bioprocesses, greater customisation... Read more ...

Associate Director/Director Translational Research - Viracta Therapeutics...

5+ years of pharmaceutical or biotechnology industry experience in oncology/cancer immunotherapy. Viracta Therapeutics, a precision oncology company focused on...From Viracta... Read more ...

Long-Term Stable Reduction of Low-Density Lipoprotein in Nonhuman Primates...

Wang, L. et al. Molecular Therapy. 6, 2019-2029 (2021). Read more ...

Mitochondrial Targeted Meganuclease as a Platform to Eliminate Mutant mtDNA...

Zekonyte, U. et al. Nat Commun. 12, 3210 (2021). Read more ...